Susquehanna International Group, LLP A Tyr Pharma Inc Put Options Transaction History

Susquehanna International Group, LLP

2 transactions

Quarter	Operation	Price Per put	puts change	puts Held	SEC Form
Q2 2023 Aug 11, 2023	BUY	$1.72 - $2.57 $94,772 - $141,607	55,100 New	55,100 $119,000
Q3 2022 Nov 14, 2022	SELL	$2.79 - $4.15 $31,527 - $46,895	-11,300 Reduced 10.3%	98,400 $295,000

37.1M

30.2K

3.1K

Ticker LIFE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,625,000
Market Cap $53.2M
Description
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.